Schedule 13D ownership disclosure

CELLECT BIOTECHNOLOGY LTD

Security class unavailable · CUSIP: 15116C102

Event date: 2017-08-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
29.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-17-008848
Form type
SC 13D
Filer
Quoin Pharmaceuticals, Ltd.
CIK
CIK 1671502
Filed
Aug 16, 2017
Reporting period
Aug 14, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub